Keyphrases
Comparative Effectiveness
100%
Combined Modality Therapy
100%
Radical Cystectomy
100%
Muscle-invasive Bladder Cancer
100%
Bladder Preserving
100%
Quality-adjusted Life Years
72%
Incremental Gains
27%
Confidence Interval
9%
Older Patients
9%
Effective Strategies
9%
Patient Selection
9%
Sensitivity Analysis
9%
Neoadjuvant Chemotherapy
9%
Survival Outcomes
9%
Markov Model
9%
Decision-analytic Model
9%
Organ Sparing
9%
Random Data
9%
Morbidity Profile
9%
Probabilistic Sensitivity Analysis
9%
Bladder-sparing
9%
Quality of Life Parameters
9%
One-way Sensitivity Analysis
9%
Utility Parameters
9%
Model Iteration
9%
Model Probability
9%
Medicine and Dentistry
Bladder
100%
Cystectomy
100%
Muscle Invasive Bladder Cancer
100%
Quality Adjusted Life Year
80%
Muscle Invasive Treatment of Bladder Cancer
20%
Clinical Stage
10%
Quality of Life
10%
Lifespan
10%
Neoadjuvant Chemotherapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Muscle Invasive Bladder Cancer
100%
Chemotherapy
20%